Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HCW Biologics (HCWB) Other Operating Expenses (2022 - 2025)

Historic Other Operating Expenses for HCW Biologics (HCWB) over the last 4 years, with Q3 2025 value amounting to $13290.0.

  • HCW Biologics' Other Operating Expenses rose 1750.66% to $13290.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $89005.0, marking a year-over-year decrease of 3579.86%. This contributed to the annual value of $86990.0 for FY2024, which is 9135.22% down from last year.
  • Latest data reveals that HCW Biologics reported Other Operating Expenses of $13290.0 as of Q3 2025, which was up 1750.66% from $16373.0 recorded in Q2 2025.
  • In the past 5 years, HCW Biologics' Other Operating Expenses registered a high of $383322.0 during Q1 2023, and its lowest value of -$176397.0 during Q1 2022.
  • Moreover, its 4-year median value for Other Operating Expenses was $25602.0 (2024), whereas its average is $96804.3.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first soared by 5835251.94% in 2023, then crashed by 9518.22% in 2024.
  • HCW Biologics' Other Operating Expenses (Quarter) stood at $342972.0 in 2022, then tumbled by 74.86% to $86237.0 in 2023, then crashed by 59.89% to $34593.0 in 2024, then tumbled by 61.58% to $13290.0 in 2025.
  • Its Other Operating Expenses was $13290.0 in Q3 2025, compared to $16373.0 in Q2 2025 and $24749.0 in Q1 2025.